Skip to main content

Clinical Drug Investigation

Ausgabe 2/1998

Inhalt (12 Artikel)

Clinical Use

Comparison of a Multidose Powder Inhaler Containing Beclomethasone Dipropionate (BDP) with a BDP Metered Dose Inhaler with Spacer in the Treatment of Asthmatic Patients

A. Poukkula, K. Alanko, K. Kilpiö, A. Knuuttila, S. Koskinen, J. Laitinen, K. Lehtonen, K. Liippo, A. Lindqvist, S. Lähelmä, M. Paananen, E.-M. Ruotsalainen, E.-R. Salomaa, M. Silvasti, U. Suuronen, P. Toivanen, V. Vilkka

Clinical Pharmacoeconomics

Cost Effectiveness of Fluticasone and Budesonide in Patients with Moderate Asthma

Karl-Otto Steinmetz, Timm Volmer, Marion Trautmann, Adrian Kielhorn

Pharmacoepidemiology

Antidepressant Prescribing Patterns

David A. Sclar, Linda M. Robison, Tracy L. Skaer, W. Michael Dickson, Christopher M. Kozma, C. Eugene Reeder

Pharmacokinetics

Pharmacokinetics and Tolerability of a New Hydroxyethyl Starch (HES) Specification [HES (130/0.4] after Single-Dose Infusion of 6% or 10% Solutions in Healthy Volunteers

Josef Waitzinger, Frank Bepperling, Günther Pabst, Jens Opitz, Margarete Müller, Jean François Baron

Pharmacovigilance

Interactions of Ceftazidime and Amikacin on Multiresistant Pseudomonas aeruginosa

Evangelos J. Giamarellos-Bourboulis, Angelos Pefanis, Paraskevi Grecka, Kyriaki Kanellakopoulou, Helen Giamarellou

Correspondence

Ritonavir-Induced Acute Renal Failure

G. Deray